© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Tilray Brands, Inc. (TLRY) stock declined over -3.42%, trading at $1.13 on NASDAQ, down from the previous close of $1.17. The stock opened at $1.16, fluctuating between $1.13 and $1.18 in the recent session.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Employees | 2650 |
Beta | 2.19 |
Sales or Revenue | $788.94M |
5Y Sales Change% | 3.784% |
Fiscal Year Ends | May |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Tilray Brands, Inc. (NASDAQ: TLRY) stock price is $1.13 in the last trading session. During the trading session, TLRY stock reached the peak price of $1.18 while $1.13 was the lowest point it dropped to. The percentage change in TLRY stock occurred in the recent session was -3.42% while the dollar amount for the price change in TLRY stock was -$0.04.
The NASDAQ listed TLRY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Tilray Brands, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Nyree Pinto
Chief HR Officer
Mr. Bernard Yeung M.B.A.
Senior Vice President of Sales & Marketing
Mr. Mitchell S. Gendel
Global Gen. Counsel & Corporation Sec.
Mr. John B. Sadler
Vice President of Investor Relations
Mr. James R. Meiers
Senior Vice President of U.S. Operations
Mr. Roger Savell
Chief Admin. Officer & Chief Financial Officer of International
Ms. Denise Menikheim Faltischek
Chief Strategy Officer & Head of International
Mr. Lloyd Brathwaite
Chief Information Officer
Mr. Bernard Yeung
Senior Vice President of Sales & Marketing
Mr. Randy Daigneau
Senior Vice President of Supply Chain
Mr. Cole Cacciavillani
Special Advisor
Ms. Berrin Noorata
Chief Corporation Affairs Officer
Mr. Victor Neufeld CA, CPA, MBA
Special Advisor
Mr. Carl A. Merton CA, CBV, CPA
Chief Financial Officer & Principal Accounting Officer
TLRY's closing price is 0% higher than its 52-week low of $1.13 where as its distance from 52-week high of $2.97 is -61.95%.
Number of TLRY employees currently stands at 2,650.
Official Website of TLRY is: https://www.tilray.com
TLRY could be contacted at phone 120 643 29325 and can also be accessed through its website. TLRY operates from 265 Talbot Street West, Leamington, ON N8H 5L4, Canada.
TLRY stock volume for the day was 36.99M shares. The average number of TLRY shares traded daily for last 3 months was 34.71M.
The market value of TLRY currently stands at $1.06B with its latest stock price at $1.13 and 937.66M of its shares outstanding.